Based on the Opko Health Inc stock forecast from 3 analysts, the average analyst target price for Opko Health Inc is USD 2.75 over the next 12 months. Opko Health Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Opko Health Inc is Bearish, which is based on 2 positive signals and 7 negative signals. At the last closing, Opko Health Inc’s stock price was USD 1.51. Opko Health Inc’s stock price has changed by -5.63% over the past week, -4.43% over the past month and -5.63% over the last year.
No recent analyst target price found for Opko Health Inc
No recent average analyst rating found for Opko Health Inc
Company Overview Opko Health Inc
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Spain, Chile, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers, and governmental units; and 4Kscore prostate cancer test. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency. This segment also develops multi-specific immune therapies focused on oncology, infectious diseases, vaccines, and immunology; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and related obesity; Somatrogon (hGH-CTP), a once-weekly human growth hormone injection; and Factor VIIa-CTP, a novel long-acting coagulation factor being developed to treat hemophilia. In addition, it develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins; develops and produces specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. The company also operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was founded in 2007 and is headquartered in Miami, Florida. Read Less
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Spain, Chile, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing...Read More
Frequently Asked Questions About Opko Health Inc (OPK) Stock
Based on ratings from 3 analysts Opko Health Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 6 buy, sell and hold ratings.
Unfortunately we do not have enough data on OPK's stock to indicate if its a good dividend stock.
Based on targets from 3 analysts, the average taret price for OPK is USD 2.75 over the next 12 months. The maximum analyst target price is USD 3 while the minimum anlayst target price is USD 2.25.
OPK stock's Price/Earning ratio is 27.12.
Our analysis grades OPK stock's Price / Earning ratio at F. This means that OPK stock's Price/Earning ratio is above 55.00000000000001% of the stocks in the Diagnostics & Research sector in the NSD exchange.
Based on this OPK may be a overvalued for its sector.
The last closing price of OPK's stock was USD 1.51.
The most recent market capitalization for OPK is USD 1.07B.
Based on targets from 3 analysts, the average taret price for OPK is projected at USD 2.75 over the next 12 months.
This means that OPK's stock price may go up by +82.12% over the next 12 months.
We can't find any ETFs which contains Opko Health Inc's stock.
As per our most recent records Opko Health Inc has 3,930 Employees.
Opko Health Inc's registered address is 4400 Biscayne Boulevard, Miami, FL, United States, 33137.
You can get more information about it from Opko Health Inc's website at https://www.opko.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Opko Health Inc (OPK) Stock
Based on ratings from 3 analysts Opko Health Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 6 buy, sell and hold ratings.
Unfortunately we do not have enough data on OPK's stock to indicate if its a good dividend stock.
Based on targets from 3 analysts, the average taret price for OPK is USD 2.75 over the next 12 months. The maximum analyst target price is USD 3 while the minimum anlayst target price is USD 2.25.
OPK stock's Price/Earning ratio is 27.12.
Our analysis grades OPK stock's Price / Earning ratio at F. This means that OPK stock's Price/Earning ratio is above 55.00000000000001% of the stocks in the Diagnostics & Research sector in the NSD exchange.
Based on this OPK may be a overvalued for its sector.
The last closing price of OPK's stock was USD 1.51.
The most recent market capitalization for OPK is USD 1.07B.
Based on targets from 3 analysts, the average taret price for OPK is projected at USD 2.75 over the next 12 months.
This means that OPK's stock price may go up by +82.12% over the next 12 months.
We can't find any ETFs which contains Opko Health Inc's stock.
As per our most recent records Opko Health Inc has 3,930 Employees.
Opko Health Inc's registered address is 4400 Biscayne Boulevard, Miami, FL, United States, 33137.
You can get more information about it from Opko Health Inc's website at https://www.opko.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for OPK !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
